Cargando…

Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development

Specialized compounds from photosynthetic organisms serve as rich resources for drug development. From aspirin to atropine, plant-derived natural products have had a profound impact on human health. Technological advances provide new opportunities to access these natural products in a metabolic cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Wurtele, Eve Syrkin, Chappell, Joe, Daniel Jones, A., Celiz, Mary Dawn, Ransom, Nick, Hur, Manhoi, Rizshsky, Ludmila, Crispin, Matthew, Dixon, Philip, Liu, Jia, Widrlechner, Mark P., Nikolau, Basil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901233/
https://www.ncbi.nlm.nih.gov/pubmed/24957774
http://dx.doi.org/10.3390/metabo2041031
_version_ 1782300823058907136
author Wurtele, Eve Syrkin
Chappell, Joe
Daniel Jones, A.
Celiz, Mary Dawn
Ransom, Nick
Hur, Manhoi
Rizshsky, Ludmila
Crispin, Matthew
Dixon, Philip
Liu, Jia
Widrlechner, Mark P.
Nikolau, Basil J.
author_facet Wurtele, Eve Syrkin
Chappell, Joe
Daniel Jones, A.
Celiz, Mary Dawn
Ransom, Nick
Hur, Manhoi
Rizshsky, Ludmila
Crispin, Matthew
Dixon, Philip
Liu, Jia
Widrlechner, Mark P.
Nikolau, Basil J.
author_sort Wurtele, Eve Syrkin
collection PubMed
description Specialized compounds from photosynthetic organisms serve as rich resources for drug development. From aspirin to atropine, plant-derived natural products have had a profound impact on human health. Technological advances provide new opportunities to access these natural products in a metabolic context. Here, we describe a database and platform for storing, visualizing and statistically analyzing metabolomics data from fourteen medicinal plant species. The metabolomes and associated transcriptomes (RNAseq) for each plant species, gathered from up to twenty tissue/organ samples that have experienced varied growth conditions and developmental histories, were analyzed in parallel. Three case studies illustrate different ways that the data can be integrally used to generate testable hypotheses concerning the biochemistry, phylogeny and natural product diversity of medicinal plants. Deep metabolomics analysis of Camptotheca acuminata exemplifies how such data can be used to inform metabolic understanding of natural product chemical diversity and begin to formulate hypotheses about their biogenesis. Metabolomics data from Prunella vulgaris, a species that contains a wide range ofantioxidant, antiviral, tumoricidal and anti-inflammatory constituents, provide a case study of obtaining biosystematic and developmental fingerprint information from metabolite accumulation data in a little studied species. Digitalis purpurea, well known as a source of cardiac glycosides, is used to illustrate how integrating metabolomics and transcriptomics data can lead to identification of candidate genes encoding biosynthetic enzymes in the cardiac glycoside pathway. Medicinal Plant Metabolomics Resource (MPM) [1] provides a framework for generating experimentally testable hypotheses about the metabolic networks that lead to the generation of specialized compounds, identifying genes that control their biosynthesis and establishing a basis for modeling metabolism in less studied species. The database is publicly available and can be used by researchers in medicine and plant biology.
format Online
Article
Text
id pubmed-3901233
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-39012332014-05-27 Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development Wurtele, Eve Syrkin Chappell, Joe Daniel Jones, A. Celiz, Mary Dawn Ransom, Nick Hur, Manhoi Rizshsky, Ludmila Crispin, Matthew Dixon, Philip Liu, Jia Widrlechner, Mark P. Nikolau, Basil J. Metabolites Article Specialized compounds from photosynthetic organisms serve as rich resources for drug development. From aspirin to atropine, plant-derived natural products have had a profound impact on human health. Technological advances provide new opportunities to access these natural products in a metabolic context. Here, we describe a database and platform for storing, visualizing and statistically analyzing metabolomics data from fourteen medicinal plant species. The metabolomes and associated transcriptomes (RNAseq) for each plant species, gathered from up to twenty tissue/organ samples that have experienced varied growth conditions and developmental histories, were analyzed in parallel. Three case studies illustrate different ways that the data can be integrally used to generate testable hypotheses concerning the biochemistry, phylogeny and natural product diversity of medicinal plants. Deep metabolomics analysis of Camptotheca acuminata exemplifies how such data can be used to inform metabolic understanding of natural product chemical diversity and begin to formulate hypotheses about their biogenesis. Metabolomics data from Prunella vulgaris, a species that contains a wide range ofantioxidant, antiviral, tumoricidal and anti-inflammatory constituents, provide a case study of obtaining biosystematic and developmental fingerprint information from metabolite accumulation data in a little studied species. Digitalis purpurea, well known as a source of cardiac glycosides, is used to illustrate how integrating metabolomics and transcriptomics data can lead to identification of candidate genes encoding biosynthetic enzymes in the cardiac glycoside pathway. Medicinal Plant Metabolomics Resource (MPM) [1] provides a framework for generating experimentally testable hypotheses about the metabolic networks that lead to the generation of specialized compounds, identifying genes that control their biosynthesis and establishing a basis for modeling metabolism in less studied species. The database is publicly available and can be used by researchers in medicine and plant biology. MDPI 2012-11-21 /pmc/articles/PMC3901233/ /pubmed/24957774 http://dx.doi.org/10.3390/metabo2041031 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Wurtele, Eve Syrkin
Chappell, Joe
Daniel Jones, A.
Celiz, Mary Dawn
Ransom, Nick
Hur, Manhoi
Rizshsky, Ludmila
Crispin, Matthew
Dixon, Philip
Liu, Jia
Widrlechner, Mark P.
Nikolau, Basil J.
Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development
title Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development
title_full Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development
title_fullStr Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development
title_full_unstemmed Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development
title_short Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development
title_sort medicinal plants: a public resource for metabolomics and hypothesis development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901233/
https://www.ncbi.nlm.nih.gov/pubmed/24957774
http://dx.doi.org/10.3390/metabo2041031
work_keys_str_mv AT wurteleevesyrkin medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT chappelljoe medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT danieljonesa medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT celizmarydawn medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT ransomnick medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT hurmanhoi medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT rizshskyludmila medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT crispinmatthew medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT dixonphilip medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT liujia medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT widrlechnermarkp medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment
AT nikolaubasilj medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment